Skip to content

GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions

Epidemiological Survey on Perioperative Hypersensitivity Reactions in France by the GERAP Network (Groupe d'étude Des réactions Anaphylactiques périopératoires)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04654923
Acronym
SERAP
Enrollment
3000
Registered
2020-12-04
Start date
2020-11-12
Completion date
2031-05-12
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersensitivity, Drug

Keywords

anaphylaxis, perioperative, hypersensitivity reactions, neuromuscular blocking agents, hypnotics

Brief summary

Perioperative hypersensitivity reactions are still associated with significant morbidity and mortality despite early recognition and use of epinephrine. The epidemiology of these reactions evolves over time and changes with clinical practice. The main objective is to study the epidemiology of these reactions over a 10-year period, including patient phenotype, reaction phenotype and outcome of the allergic work-up.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Minor and major subject * Subject having experienced a perioperative hypersensitivity reaction between January the 1st 2017 and December the 31st 2027. * Referred for an allegro-anesthetic workup * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

* Subject having expressed opposition to participating in the study * Inability to provide the subject with research information * Subject under guardianship or guardianship * Subject under safeguard of justice

Design outcomes

Primary

MeasureTime frame
Retrospective analysis of incidence of all perioperative hypersensitivity reactions referred in an allegro-anestheticOutcome is analysed every 2 years over a 10 years period

Countries

France

Contacts

Primary ContactPaul-Michel MERTES, MD, PhD
paul-michel.mertes@chru-strasbourg.fr33 3 69 55 04 44
Backup ContactCharles TACQUARD, MD
charlesambroise.tacquard@chru-strasbourg.fr33.3.69.55.16.08

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026